AFM13 IN PATIENTS WITH CD30 POSITIVE RELAPSED OR REFRACTORY (R/R) PERIPHERAL T CELL LYMPHOMA (PTCL): RESULTS FROM THE PHASE 2 REDIRECT STUDY

Kim, W. S., Shortt, J., Zinzani, P. L., Mikhaylova, N., Marin‐Niebla, A., Radeski, D., Ribrag, V., Domenech, E. D., Sawas, A., Alexis, K., Emig, M., Garcia, L., Overesch, A., Pietzko, K., & Horwitz, S. (2023). AFM13 IN PATIENTS WITH CD30 POSITIVE RELAPSED OR REFRACTORY (R/R) PERIPHERAL T CELL LYMPHOMA (PTCL): RESULTS FROM THE PHASE 2 REDIRECT STUDY. Hematological Oncology, 41(S2), 195–196. Portico. https://doi.org/10.1002/hon.3163_126
Authors:
W. S. Kim
Jake Shortt
Pier Luigi Zinzani
N. M. Mikhaylova
Ana Marín‐Niebla
Dejan Radeski
Vincent Ribrag
Eva Domingo‐Doménech
Ahmed Sawas
Karenza Alexis
Michael Emig
Lucía García
Andre Overesch
Kerstin Pietzko
Steven M. Horwitz
Affiliated Authors:
Ahmed Sawas
Columbia Affiliation:
Subjects:
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Lymphoid Neoplasms (OpenAlex Topic)
Natural Killer Cells in Immunity (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1002/hon.3163_126
DOI:
10.1002/hon.3163_126
Journal:
Hematological Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: